Aller au contenu principal
Profil bibliographique

Hisaya Tanaka

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
58Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Esophageal Cancer Research and TreatmentLung Cancer Diagnosis and TreatmentHepatitis C virus researchSystemic Lupus Erythematosus ResearchSleep and related disorders

Les publications récentes

Accès ouvert 2025 article OpenAlex

Evaluation of the Prognostic Value of Quantitative and Visual Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) Parameters in Superficial Esophageal Squamous Cell Carcinoma

Arman Nessipkhan, Reiko Ideguchi, Yuko Akazawa, Hisaya Tanaka et autres

INTRODUCTION: Early diagnosis is crucial for improving outcomes in esophageal cancer, as prognosis is strongly dependent on the stage at detection. This study evaluated the prognostic value of quantitative and visual 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters in patients with …

jp, kz (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2024 article OpenAlex

18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma

Hisaya Tanaka, Keiichi Hashiguchi, Maiko Tabuchi, Arman Nessipkhan et autres

Endoscopic submucosal dissection is a standard treatment for early esophageal squamous cell carcinoma. However, submucosal or lymphovascular invasion increases the risk of lymph node metastasis. Although 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters are associated with prognosis in patients with …

jp (code pays fourni par la source)

4 citations Scientific Reports
Accès ouvert 2020 article OpenAlex

Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient

Yasuki Shingu, Tomohiro Nakata, Shinji Sawai, Hisaya Tanaka et autres

BACKGROUND: Erythropoietin-stimulating agents (ESAs) are used to treat anemia in patients with chronic kidney disease, enabling maintenance of stable hemoglobin levels and eliminating the need for multiple transfusions. Epoetin-beta pegol (C.E.R.A.) is a continuous erythropoietin receptor activator created by integrating a large …

jp (code pays fourni par la source)

10 citations BMC Nephrology
Accès ouvert 2019 article OpenAlex

Changes in serum LDL, PCSK9 and microRNA‑122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir

Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, Naota Taura et autres

The present study evaluated the changes in lipid profile, and the associations between serum protein convertase subtilisin/kexin 9 (PCSK9), microRNA (miR)122 and low-density lipoprotein variation following treatment of hepatitis C virus (HCV) genotype 1b infection with Daclatasvir/Asunaprevir. A total of 39 patients …

jp (code pays fourni par la source)

19 citations Biomedical Reports
Accès ouvert 2017 article OpenAlex

Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals

Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, Naota Taura et autres

AIM: Direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection have a significantly high sustained virologic response rate after a short treatment course and do not have any severe adverse effects. Patient-reported outcomes (PROs) have become increasingly important to …

jp (code pays fourni par la source)

25 citations Hepatology Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.